Resource

 

 

 

 

 

 

 

 

 

 

 

M&A

Hogan Lovells advises BASF on combining paper and water chemicals business with Solenis

04 May 2018

Led by Munich partner Nikolas Zirngibl international law firm Hogan Lovells advised BASF SE on combining its paper and water chemicals business with US specialty chemical company Solenis.

BASF contributes its paper and water chemicals business from its Performance Chemicals division with locations in Bradford and Grimsby (UK), Suffolk (Virginia, USA), Altamira (Mexico), Ankleshwar (India) and Kwinana (Australia) and approx. 1,300 employees into the new corporation. The combined entity generated in 2017 pro-forma sales of around 2.4 bn Euros.

MoFo Advises Sprint and SoftBank in Industry-changing Merger of Sprint and T-Mobile

02 May 2018

Morrison & Foerster is lead legal counsel to Sprint Corp. and for SoftBank Group Corp., the controlling shareholder of Sprint, on the landmark merger of Sprint and T-Mobile US Inc. announced on April 29, 2018.  Based on closing share prices on April 27, the total implied enterprise value for Sprint is approximately $59 billion and the aggregate for the combined company in the all-stock transaction is approximately $146 billion.

Osborne Clarke advises Community Fibre on £25M financing round led by NDIF

24 Apr 2018

Osborne Clarke has advised Community Fibre, the ultra-fast full-fibre Internet Service Provider, on a £25 million new financing round led by the National Digital Infrastructure Fund (NDIF) to rollout full-fibre connectivity to a further 100,000 homes by 2019, covering social and private housing estates across London. A follow-on investment will be made by leading long-term institutional investor, RPMI Railpen.

DLA Piper advising Atlas on combination with Mineral Resources

10 Apr 2018

DLA Piper is advising Atlas Iron Limited (ASX: AGO) on its agreement with Mineral Resources Limited (ASX: MIN) to combine by way of scheme of arrangement in a deal that values the iron ore miner at AU$297.6 million.

The DLA Piper team was led by Perth-based Corporate partners Michael Bowen and Scott Gibson with special counsel Hedley Roost, senior associate Cameron Bill and solicitor Sarah Fay.

Expansion of renewable energy in Russia: CMS advising on the acquisition and development of 9 photovoltaic parks

09 Apr 2018

Russia has already made advances in the renewable energy sector over recent years and is on the offensive in the solar energy sector. This development offers new opportunities for Austrian companies, too. GREEN SOURCE and CORE VALUE CAPITAL are currently implementing one of the biggest current projects in Russia across a total of 9 photovoltaic parks. The two Vienna-based companies have retained CMS as their legal advisors.

Simpson Thacher Represents the Special Committee of the Board of Directors of iKang Healthcare Group in Proposed Going Private Transaction

30 Mar 2018

The Firm is representing the Special Committee of the Board of Directors of iKang Healthcare Group, Inc. (“iKang”) (NASDAQ: KANG), a major provider in China’s fast-growing private preventive healthcare services market, in connection with a proposed going private transaction by a consortium comprised of affiliates of Yunfeng Capital and Alibaba Group Holding Limited (the “Sponsors”).

Baker McKenzie advises on UK's first demerger in 5 years

29 Mar 2018

Leading global law firm Baker McKenzie is advising FTSE 250 company BGEO Group PLC on the demerger of its investment business from the banking business. This will involve the insertion of a new parent company by way of scheme of arrangement and premium listings of both banking and investment businesses. It is currently expected that both will be FTSE 250 companies. Announced yesterday and, subject to shareholder approval, expected to close in May 2018, this will be the first demerger by way of scheme of arrangement involving London premium listed companies since 2012.

Addleshaw Goddard advises on landmark merger of Derby and Burton NHS Foundation Trusts

19 Mar 2018

Addleshaw Goddard’s Healthcare sector team have advised on the Derby and Burton Foundation Trust merger. This is only the second NHS merger to be cleared at Phase One on the basis of patient benefits.

Following its review of the merger, the CMA decided that the benefits to patients across a number of specialities for the combined Trust outweighed any potential competition concerns with regards to the overlap in a number of healthcare services offered by both.